PPARα regulates endothelial progenitor cell maturation and myeloid lineage differentiation through a NADPH oxidase-dependent mechanism in mice

Stem Cells

Volumn 33, Issue 4, 2015, Pages 1292-1303

  Vergori, Luisa ^a,b,c   Lauret, Emilie ^a   Gaceb, Abderahim ^a   Beauvillain, Céline ^c,d   Andriantsitohaina, Ramaroson ^a,c   Carmen Martinez, M ^a,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITY OF BARI   (Italy)

^d ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Bone marrow; Differentiation; Endothelial cell; Hematopoietic progenitors

Indexed keywords

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; COLONY STIMULATING FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; BONE MARROW PROGENITOR CELL; CAROTID ARTERY INJURY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL LINEAGE; CELL MATURATION; CELLULAR PARAMETERS; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GENE DELETION; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; LYMPH NODE CELL; LYMPHOCYTE; LYMPHOID CELL; MACROPHAGE; MALE; MONOCYTE; MONOCYTIC PROGENITOR CELL; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RE ENDOTHELIALIZATION; SPLEEN CELL; THYMOCYTE; WILD TYPE MOUSE; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL MOTION; PHYSIOLOGY;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL PROGENITOR CELLS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; PPAR ALPHA;

EID: 84925679789     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1924     Document Type: Article

References (44)

1. Ratajczak MZ, Zuba-Surma EK, Wojakowski W, et al. Bone marrow-home of versatile stem cells. Transfus Med Hemother 2008; 35: 248-259.
2. Cesselli D, Beltrami AP, Rigo S, et al. Multipotent progenitor cells are present in human peripheral blood. Circ Res 2009; 104: 1225-1234.
3. Li Calzi S, Neu MB, Shaw LC, et al. EPCs and pathological angiogenesis: When good cells go bad. Microvasc Res 2010; 79: 207-216.
4. Krey G, Braissant O, L'Horset F, et al. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 1997; 11: 779-791.
5. Calkin AC, Thomas MC,. PPAR agonists and cardiovascular disease in diabetes. PPAR Res 2008; 2008: 245410.
6. Sharifpanah F, Wartenberg M, Hannig M, et al. Peroxisome proliferator-activated receptor alpha agonists enhance cardiomyogenesis of mouse ES cells by utilization of a reactive oxygen species-dependent mechanism. Stem Cells 2008; 26: 64-71.
7. Benameur T, Tual-Chalot S, Andriantsitohaina R, et al. PPAR-α is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One 2010; 5: e12392.
8. Yang Q, Gonzalez FJ,. Peroxisome proliferator-activated receptor alpha regulates B lymphocyte development via an indirect pathway in mice. Biochem Pharmacol 2004; 68: 2143-2150.
9. Ito K, Hirao A, Arai F, Takubo K, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006; 12: 446-451.
10. Jang YY, Sharkis SJ,. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007; 110: 3056-3063.
11. Owusu-Ansah E, Banerjee U,. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature 2009; 461: 537-541.
12. Lee SS, Pineau T, Drago J, et al. Targeted disruption of the alpha isoform of the peroxisome proliferator- activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 1995; 15: 3012-3022.
13. Lindner V, Fingerle J, Reidy MA,. Mouse model of arterial injury. Circ Res 1993; 73: 792-796.
14. Kerstin S, Seydoux J, Peters JM, et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-1498.
15. Wilson A, Trumpp A,. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006; 6: 93-106.
16. Poyton RO, Ball KA, Castello PR,. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab 2009; 20: 332-340.
17. Paravicini TM, Touyz RM,. NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care 2008; 31 (suppl 2): S170-180.
18. Babior BM,. NADPH oxidase: An update. Blood 1999; 93: 1464-1476.
19. Lambeth JD,. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4: 181-189.
20. Dubrac S, Elentner A, Schoonjans K, et al. Lack of IL-2 in PPAR-α-deficient mice triggers allergic contact dermatitis by affecting regulatory T cells. Eur J Immunol 2011; 41: 1980-1991.
21. Gelinas DS, McLaurin J,. PPAR-alpha expression inversely correlates with inflammatory cytokines IL-1beta and TNF-alpha in aging rats. Neurochem Res 2005; 30: 1369-1375.
22. Jian B, Yang S, Chen D, et al. Aging influences cardiac mitochondrial gene expression and cardiovascular function following hemorrhage injury. Mol Med 2011; 17: 542-549.
23. Banfi C, Auwerx J, Poma F, et al. Induction of plasminogen activator inhibitor I by the PPARα ligand, Wy-14,643, is dependent on ERK 1/2 signaling pathway. Thromb Haemost 2003; 90: 611-619.
24. Vu-Dac N, Schoonjans K, Laine B, et al. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element. J Biol Chem 1994; 269: 31012-31018.
25. Zhang X, Tanaka N, Nakajima T, et al. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation. Biochem Biophys Res Commun 2006; 346: 1307-1311.
26. Yokoyama M, Suto Y, Sato H, et al. Low serum lipids suggest severe bone marrow failure in children with aplastic anemia. Pediatr Int 2000; 42: 613-619.
27. Murphy AJ, Akhtari M, Tolani S, et al. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest 2011; 121: 4138-4149.
28. Desvergne B, Wahli W,. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 1999; 20: 649-688.
29. Cuthbert JA, Lipsky PE,. Lipoproteins may provide fatty acids necessary for human lymphocyte proliferation by both low-density lipoprotein receptor-dependent and -independent mechanisms. J Biol Chem 1989; 264: 13468-13474.
30. Reya T, Morrison SJ, Clarke MF, Weissman IL,. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
31. Favre J, Terborg N, Horrevoets AJ,. The diverse identity of angiogenic monocytes. Eur J Clin Invest 2013; 43: 100-107.
32. Awad O, Jiao C, Ma N, et al. Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 2005; 23: 575-583.
33. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117: 195-205.
34. Zhana Y, Xuc Y, Lewa AM,. The regulation of the development and function of dendritic cell subsets by GM-CSF: More than a hematopoietic growth factor. Mol Immunol 2012; 52: 30-37.
35. Lv Y, Hou X, Ti Y, et al. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome. Clin Nutr 2013; 32: 849-854.
36. Fenyo IM, Ganfecu AV,. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology 2013; 218: 1376-1384.
37. Urao N, Ushio-Fukai M,. Redox regulation of stem/progenitor cells and bone marrow niche. Free Radic Biol Med 2013; 54: 26-39.
38. Inoue Y, Yagisawa M, Saeki K, et al. Induction of phagocyte oxidase components during human myeloid differentiation: Independent protein expression and discrepancy with the function. Biosci Biotechnol Biochem 2001; 65: 2581-2584.
39. Gavazzi G, Banfi B, Deffert C, et al. Decreased blood pressure in NOX1-deficient mice. FEBS Lett 2006; 580: 497-504.
40. Pollock JD, Williams DA, Gifford MA, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet 1995; 9: 202-209.
41. Paffenholz R, Bergstrom RA, Pasutto F, et al. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 2004; 18: 486-491.
42. Dernbach E, Urbich C, Brandes RP, et al. Antioxidative stress-associated genes in circulating progenitor cells: Evidence for enhanced resistance against oxidative stress. Blood 2004; 104: 3591-3597.
43. Girnun GD, Domann FE, Moore SA, et al. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 2002; 16: 2793-2801.
44. Toyama T, Nakamura H, Harano Y, et al. PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324: 697-704.